Insider · CIK 0001834412
Carl L. G. Hansen
ceoofficerdirectorowner
Files at ABCL (AbCellera Biologics Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | ABCL AbCellera Biologics Inc. | AGrant or award Share option (right to buy)derivative | +2,730,109 | $0.00 | $0 | 10,990,332 | Jan 3, 2025 |
| Nov 25, 2024 | ABCL AbCellera Biologics Inc. | MOption exercise Common Shares | +56,125 | $2.70 | $152k | 898,000 | Nov 26, 2024 |
| Nov 25, 2024 | ABCL AbCellera Biologics Inc. | MOption exercise Share option (right to buy)derivative | -56,125 | $0.00 | $0 | 8,260,223 | Nov 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.